All In Biotech

Drug Trial Radar · NCT06947941

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Psychosis Associated With Alzheimer's Disease

Last checked: Nov 19, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 325 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

325

Planned (sponsor's estimate)

Start

Mar 25, 2026

Primary completion

Feb 21, 2028

Study completion Mar 20, 2028

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Apr 27, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 55 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate KarXT + KarX-EC as a treatment for psychosis associated with Alzheimer's disease.

Conditions

  • Alzheimer Disease
  • Psychosis

Interventions

  • KarXTDrug

    Specified dose on specified days

  • KarX-ECDrug

    Specified dose on specified days

  • KarXT + KarX-EC Arm Matching PlaceboDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Neuropsychiatric Inventory-Clinician: Hallucinations and Delusions (NPI-C: H+D) ScoreTime frame: Up to approximately Week 14

Locations

22 sites in 5 countries. Site status is shown where the registry gives one.

  • Gilbert Neurology Partners/CCT Research

    Gilbert, Arizona · Recruiting

  • Inland Psychiatric Medical Group.

    Chino, California · Recruiting

  • Local Institution - 0001

    Naples, Florida · Withdrawn

  • Local Institution - 1401

    Naples, Florida · Not yet recruiting

  • Local Institution - 0029

    Cleveland, Ohio · Not yet recruiting

  • Insight Clinical Trials LLC - Independence

    Independence, Ohio · Recruiting

  • Local Institution - 0020

    Macquarie Park, New South Wales, Australia · Not yet recruiting

  • Local Institution - 0052

    Nedlands, Western Australia, Australia · Not yet recruiting

  • Local Institution - 0054

    Toronto, Ontario, Canada · Not yet recruiting

  • Local Institution - 0027

    Whitby, Ontario, Canada · Not yet recruiting

  • Local Institution - 0025

    Montreal, Quebec, Canada · Not yet recruiting

  • Local Institution - 0035

    Nankoku-shi, Japan · Not yet recruiting

  • Local Institution - 0034

    Osaka, Japan · Not yet recruiting

  • Local Institution - 0040

    Suita, Osaka, Japan · Not yet recruiting

  • Local Institution - 0018

    Crowborough, United Kingdom · Withdrawn

  • Local Institution - 0024

    London, United Kingdom · Not yet recruiting

  • Local Institution - 0004

    Motherwell, United Kingdom · Not yet recruiting

  • Local Institution - 0005

    Exeter, Devon, United Kingdom · Not yet recruiting

  • Local Institution - 0023

    London, England, United Kingdom · Not yet recruiting

  • Local Institution - 0015

    Oxford, Oxfordshire, United Kingdom · Withdrawn

  • Local Institution - 0009

    Chertsey, Surrey, United Kingdom · Not yet recruiting

  • Local Institution - 0017

    Sheffield, Yorkshire and the Humber, United Kingdom · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.